← Leaderboards
Timothy Michael Chlon
Cincinnati Childrens Hosp Med Ctr
$1,455,810
Attributed
$1,455,810
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $586.2K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,455,810 · 4
By mechanism
K01$711,271 · 1
R56$435,804 · 1
R03$240,750 · 1
F32$67,985 · 1
Top collaborators
No co-investigators on record.
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Daniel Starczynowski$17,551,895
- Gang Huang$4,401,757
- Marie-Dominique Filippi$10,758,550
- Damien Reynaud$3,261,994
- Molly Anne Smith$105,223
Others in their field
Other Emerging Leaders on “Amino Acid Substitution”
- Chitra Upadhyay · Icahn School Of Medicine At Mount Sinai$3,286,181
- Jacquelyn Gorman · Oklahoma Medical Research Foundation$3,130,679
- Maliha Zahid · Vivasc Therapeutics Inc.$2,981,992
- Daniel Carl Lee · University Of South Florida$2,697,589
- Nicholas C. Wu · University Of Illinois At Urbana-Champaign$2,673,249
- Aditya Mohan Kunjapur · University Of Delaware$2,353,079
Research focus
Amino Acid SubstitutionHematopoietic Stem CellsRna HelicaseMutationHeterozygoteIn VivoHematopoieticProteinsInheritedMutantDysmyelopoietic SyndromesAdultMolecularCellsDefectHelicase GeneHematopoiesisPathogenesisAllelesMissense MutationKnock-OutPhenotypeHematologic NeoplasmsHematological Disease
Grant awards (9)
Advanced Mouse Models of DDX41-mutated Myelodysplastic Syndromes$120,375
R03 · FY2025 · DK · contact PI
Advanced Mouse Models of DDX41-mutated Myelodysplastic Syndromes$120,375
R03 · FY2024 · DK · contact PI
Decoding the Paradox of DDX41-mutant MDS$435,804
R56 · FY2023 · HL · contact PI
The Role of DDX41 in Inherited Myelodysplastic Syndromes$150,444
K01 · FY2023 · DK · contact PI
The Role of DDX41 in Inherited Myelodysplastic Syndromes$150,444
K01 · FY2022 · DK · contact PI
The Role of DDX41 in Inherited Myelodysplastic Syndromes$150,444
K01 · FY2021 · DK · contact PI
The Role of DDX41 in Inherited Myelodysplastic Syndromes$150,444
K01 · FY2020 · DK · contact PI
The Role of DDX41 in Inherited Myelodysplastic Syndromes$109,495
K01 · FY2019 · DK · contact PI
Pathogenesis of Inherited Myelodysplastic Syndromes$67,985
F32 · FY2018 · HL · contact PI